NASDAQ · Biotechnology

MDWD (MDWD) Stock

$14.35 -1.85% NASDAQ: MDWD Healthcare

Valuation

MetricValue
Price$14.35
Market Cap$184.34M
P/E Ratio-7.94
P/B Ratio4.12
P/S Ratio10.81
EPS (TTM)$-2.10
52-Week High$21.25
52-Week Low$13.54
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-54.55%
ROA-27.91%
ROCE-48.08%
Gross Margin-147.06%
Operating Margin-147.06%
Net Margin-1.41%
Debt/Equity0.20
Current Ratio2.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$24.0M$26.0M$19.0M$20.0M$17.0M
Operating Profit$-11.0M$-8.0M$-16.0M$-19.0M$-25.0M
Net Profit$-14.0M$-20.0M$-7.0M$-30.0M$-24.0M
EPS$-3.48$-3.93$-0.75$-3.03$-2.10
Op Margin-47.2%-28.9%-83.0%-95.8%-149.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$20.0M$50.0M$66.0M$73.0M$86.0M
Total Liabilities$24.0M$39.0M$35.0M$42.0M$34.0M
Cash$11.0M$34.0M$12.0M$9.0M$5.0M
Borrowings$1.0M$1.0M$6.0M$7.0M$9.0M

Latest News

Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating MT Newswires · May 28, 2026 Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely? Simply Wall St. · May 28, 2026 MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue ... GuruFocus.com · May 27, 2026 MediWound (MDWD) Q1 2026 Earnings Transcript Motley Fool · May 27, 2026 MediWound Q1 Earnings Call Highlights MarketBeat · May 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-9.0M$-12.0M$-10.0M$-14.0M$-15.0M
Investing Cash Flow$3.0M$-1.0M$-41.0M$-15.0M$-25.0M
Financing Cash Flow$-1.0M$-3.0M$-2.0M$-2.0M$-1.0M
Net Cash Flow$-6.0M$23.0M$-22.0M$-3.0M$-4.0M
Free Cash Flow$-9.0M$-12.0M$-17.0M$-20.0M$-20.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-11.35%
Quick Ratio2.17
Interest Coverage-25.00
Return 1Y-30.39%
Return 3Y42.84%
Return 5Y-56.03%

Ownership

Insiders Held15.86%
Institutions Held58.46%
Institutions Float Held69.48%
Institutional HolderSharesReport Date
Investor AB872,0932026-03-31
Yelin Lapidot Holdings Management Ltd.762,8172026-03-31
Rosalind Advisors, Inc.749,0542026-03-31
Price (T.Rowe) Associates Inc709,8472026-03-31
Blackrock Inc.445,8342026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About MDWD

MDWD is led by CEO Ofer Gonen, employs 111 people, headquartered in IL, publicly traded since 2014.

MDWD stock trades at $14.35 with a market capitalization of $184.34M. The stock is valued at a price-to-earnings (P/E) ratio of -7.94, price-to-book of 4.12, price-to-sales of 10.81. Over the past 52 weeks the stock has ranged between $13.54 and $21.25, and currently trades 32.5% below its 52-week high.

On profitability, MDWD generates a return on equity (ROE) of -54.55%, return on capital employed of -48.08%, an operating margin of -147.06%, a net profit margin of -1.41%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides